(From Asia Pulse)
BRISBANE, Feb 25 Asia Pulse - Australian biochemical company Tissue Therapies Ltd, which has exclusive rights to a new tissue culture and repair technology, yesterday said it planned to list on the stock exchange.
The Brisbane-based company has lodged a prospectus with the Australian Securities and Investment Commission to raise A$3.5 million (US$2.72 million) in an initial public offering.
The company, formed to commercialise tissue culture discoveries from the Queensland University of Technology, will issue seven million new shares at 50 cents each, with the offer expected to open on March 2.
After listing on the …